We asked Professor Rebecca Edelmayer, Vice President of Scientific Engagement at the Alzheimer's Association about important news about the diagnosis and treatment of dementia at AAIC 2025.
Important Websites
ALZPro -- Your central hub offering the latest clinical guidelines, education and training, research publications and practical tools for researchers, clinicians and dementia care providers. Built to empower all dementia professionals, ALZPro delivers timely, relevant resources to advance evidence-informed, person-centered care.
ALZ-NET -- Collects clinical and safety data about patients being evaluated for memory concerns or receiving new FDA-approved treatments for Alzheimer’s disease, including drugs/medications and devices, and tracks the long-term health outcomes associated with their use in real-world settings. ALZ-NET is a voluntary health care provider-enrolled patient network.
U.S. POINTER -- A clinical trial to evaluate whether lifestyle interventions that simultaneously target multiple risk factors protect cognitive function in older adults (age 60-79) at increased risk for cognitive decline. It is the first such study to be conducted in a large group of U.S. residents.
https://www.alz.org/us-pointer/home.asp
https://www.alz.org/us-pointer/study-results.asp
AAIC 2026 -- London
